{"id":"W2516537857","doi":"10.1002/ajh.24536","title":"Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Bosutinib; Medicine; Nilotinib; Dasatinib; Internal medicine; Imatinib; Cumulative incidence; Adverse effect; Nausea; Myeloid leukemia; Gastroenterology; Oncology; Cohort","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004213244,0.0004745465,0.002069094,0.0003661497,0.00007032457,0.00001285897,0.0003028819,0.0001747935,0.0007563313],"category_scores_gemma":[0.0004284189,0.0002878034,0.000407072,0.0002788465,0.001241892,0.0002099437,0.0001065575,0.0003405265,0.00002200201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002378614,"about_ca_system_score_gemma":0.004695255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002197205,"about_ca_topic_score_gemma":0.00007846752,"domain_scores_codex":[0.9965968,0.0001444603,0.001597187,0.0004685284,0.0004059141,0.0007870748],"domain_scores_gemma":[0.9957336,0.0009265122,0.001935763,0.0005924143,0.0003729321,0.0004387754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04346398,0.001711409,0.09079879,0.004056955,0.004915937,0.003927639,0.002783921,0.00001165091,0.07453551,0.001027621,0.00622024,0.7665464],"study_design_scores_gemma":[0.3659119,0.1675823,0.07311727,0.01478882,0.006166178,0.1401184,0.002022649,0.0006795864,0.2015271,0.0006519215,0.02453613,0.002897767],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895878,0.003323348,0.003537605,0.002293182,0.0002372874,0.0008319357,0.00008132976,0.00003371273,0.00007376886],"genre_scores_gemma":[0.9918969,0.0006729115,0.006175578,0.0002412242,0.0004855394,0.00008915446,0.00001342798,0.00009001164,0.0003352492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7636486,"threshold_uncertainty_score":0.9999574,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01464961286399839,"score_gpt":0.3128337850963781,"score_spread":0.2981841722323797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}